Sign In
Buy AERI
$15.25
+0 (+0%)
At Close: Feb 17, 2023
Aerie Pharma (AERI) Received its Third Buy in a Row
01:09pm, Friday, 20'th Mar 2020
After H.C. Wainwright and Mizuho Securities gave Aerie Pharma (NASDAQ: AERI) a Buy rating last month, the company received another Buy, this time from
Aerie Pharma (AERI) Received its Third Buy in a Row
01:09pm, Friday, 20'th Mar 2020
After H.C. Wainwright and Mizuho Securities gave Aerie Pharma (NASDAQ: AERI) a Buy rating last month, the company received another
Mizuho Securities Sticks to Their Buy Rating for Aerie Pharma (AERI)
01:04pm, Friday, 20'th Mar 2020
Mizuho Securities analyst Difei Yang maintained a Buy rating on Aerie Pharma (AERI) today and set a price target of $54.00. The company's shares closed
Mizuho Securities Sticks to Their Buy Rating for Aerie Pharma (AERI)
01:04pm, Friday, 20'th Mar 2020
Mizuho Securities analyst Difei Yang maintained a Buy rating on Aerie Pharma (AERI – Research Report) today and set a
$21.19 Million in Sales Expected for Aerie Pharmaceuticals Inc (NASDAQ:AERI) This Quarter
07:18am, Friday, 20'th Mar 2020
Analysts expect that Aerie Pharmaceuticals Inc (NASDAQ:AERI) will post $21.19 million in sales for the current quarter, according to Zacks. Six analysts have provided estimates for Aerie Pharmaceutica
The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection
11:37am, Thursday, 19'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 18) * Biomerica, Inc. (NASDAQ: BMRA)( announced comm
Aerie Pharma (AERI) Received its Third Buy in a Row
02:25am, Thursday, 19'th Mar 2020
After Mizuho Securities and H.C. Wainwright gave Aerie Pharma (NASDAQ: AERI) a Buy rating last month, the company received another Buy, this time from
Aerie Pharma (AERI) Received its Third Buy in a Row
02:25am, Thursday, 19'th Mar 2020
After Mizuho Securities and H.C. Wainwright gave Aerie Pharma (NASDAQ: AERI) a Buy rating last month, the company received another
The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection
12:00am, Thursday, 19'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week highs on March 18)
Biomerica, Inc. (NASDAQ...
The Daily Biotech Pulse: AbbVie, Allergan Agree On Divestments, Obalon Stops Obesity Balloon Sale, COVID-19 Updates
11:36am, Wednesday, 18'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 17) * BioNTech SE - ADR (NASDAQ: BNTX) * Regeneron P
The Daily Biotech Pulse: AbbVie, Allergan Agree On Divestments, Obalon Stops Obesity Balloon Sale, COVID-19 Updates
07:36am, Wednesday, 18'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 17) …
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs March 16.) * BioNTech SE - ADR (NASDAQ: BNTX) (announced eff
Contrasting Surface Oncology (NASDAQ:SURF) & Aerie Pharmaceuticals (NASDAQ:AERI)
05:36am, Tuesday, 17'th Mar 2020
Surface Oncology (NASDAQ:SURF) and Aerie Pharmaceuticals (NASDAQ:AERI) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strengt
Franklin Resources Inc. Purchases New Position in Aerie Pharmaceuticals Inc (NASDAQ:AERI)
09:58am, Sunday, 15'th Mar 2020
Franklin Resources Inc. purchased a new stake in Aerie Pharmaceuticals Inc (NASDAQ:AERI) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 1,1
Is Aerie Pharmaceuticals, Inc.’s (NASDAQ:AERI) CEO Being Overpaid?
12:34pm, Saturday, 14'th Mar 2020
Vince Anido became the CEO of Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) in 2013. First, this article will compare CEO...
